Febrile Seizures Market Research Report - Global Forecast till 2027

Febrile Seizures Market Research Information: by Type (Simple, Complex), Diagnosis (Physical Examination, Laboratory Tests, Electroencephalogram (Eeg)), Treatment (Home Management, Antipyretic Medication), Distribution Channel – Global Forecast till 2027

ID: MRFR/HC/3812-HCR | | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


A febrile seizure is one of the most common neurological disorders observed in the pediatric age group. According to the International League Against Epilepsy (ILAE), febrile seizure, in childhood, occur as a seizure event featured with temperature over 38°C without any evidence of electrolyte imbalances in CNS infection or history. There are two types of febrile seizures i.e. simple or complex. The simple febrile seizure is the most common type associated with unconsciousness and rhythmic twitching of the arms or legs. Complex febrile seizures are less common but can last more than 15 minutes.


According to a study published in the Iranian Journal of Child Neurology in 2014, it is found that the pooled prevalence of febrile seizures in Iran was 47.9%.


Notably, growing public awareness and technological advancements are the key factors driving the febrile seizures market. Nowadays, people are becoming more aware of different types of neurological disorders. Government and other different organizations have started educating people about hygiene and diseases through seminars, and conferences. People are becoming more aware and health conscious. Thus, increasing awareness has provided a push to the growth of the market.


The prevalence rate of febrile seizures has been decreasing from childhood to adulthood, suggested by the national epidemiological survey.


Various other factors such as increasing incidence of neurological disorders, unmet medical needs, increasing government assistance, rising healthcare expenditure, improving regulatory framework, and rising funding and reimbursement are continuously contributing to the growth of the global febrile seizures market. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion, which is further followed by France with EUR 237 billion, and United Kingdom with EUR 223 billion.


Despite these drivers, there are some issues associated with febrile seizures market. Some of the challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs, and poor healthcare system in low and middle-income countries may hinder the growth of the market to an extent.


It is estimated that the febrile seizures market is expected to grow at a CAGR 5.5% during the forecast period of 2017-2023.


Key Players


Some of the key players in the global febrile seizures market are Sanofi, Cardinal Health, Merck, Pfizer, Johnson & Johnson, Abbott Laboratories, GlaxoSmithKline plc, Cephalon Inc., Shire, and UCB S.A, and others.


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities


Segmentation


The global febrile seizures market is segmented on the basis of type, diagnosis, treatment, and distribution channels.


On the basis of the type, the market is classified as simple febrile seizure and complex febrile seizure.


On the basis of the diagnosis, the market is classified as physical examination, laboratory tests, electroencephalogram (EEG), and others. The laboratory tests are further segmented into blood tests, urine tests, and lumbar puncture.


On the basis of the treatment, the market is classified as home management, antipyretic medication, and others.


On the basis of the distribution channel, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.


Research Methodology
Febrile Seizures Market


Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis


The Americas dominate the global febrile seizures market owing to the rising awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.


Europe holds the second position in the febrile seizures market. It is expected that the support provided by the government bodies for research & development and improvement in the reimbursement policies in the healthcare is likely to drive the market of the European region.


The Asia Pacific is the fastest growing febrile seizures market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.


The Middle East & Africa holds the least market share due to lack of technical knowledge and poor medical facilities.



Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Febrile Seizure Market, by Type

6.1 Introduction

6.2 Simple Febrile Seizure

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Complex Febrile Seizure

6.3.1 Market Estimates & Forecast, 2020-2027

Chapter 7. Global Febrile Seizure Market, by Diagnosis

7.1 Introduction

7.2 Physical Examination

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Laboratory Tests

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Electroencephalogram (EEG)

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Others

7.5.1 Market Estimates & Forecast, 2020-2027

Chapter 8. Global Febrile Seizure Market, by treatment

8.1 Introduction

8.2 Home Management

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Antipyretic Medication

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Others

8.4.1 Market Estimates & Forecast, 2020-2027

Chapter 9. Global Febrile Seizure Market, by Distribution Channel

9.1 Introduction

9.2 Hospitals

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Clinics

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Diagnostic Centers

9.4.1 Market Estimates & Forecast, 2020-2027

9.5 Drug Stores

9.5.1 Market Estimates & Forecast, 2020-2027

9.6 Pharmacies

9.6.1 Market Estimates & Forecast, 2020-2027

9.7 Others

9.7.1 Market Estimates & Forecast, 2020-2027

Chapter 10. Global Febrile Seizure Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Sanofi

12.1.1 Company Overview

12.1.2 Types Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Cardinal Health

12.2.1 Company Overview

12.2.2 Types Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Merck

12.3.1 Company Overview

12.3.2 Types Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Pfizer

12.4.1 Company Overview

12.4.2 Types/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Johnson & Johnson

12.5.1 Company Overview

12.5.2 Types Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Johnson & Johnson Private Limited

12.6.1 Company Overview

12.6.2 Types Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 ABBOTT LABORATORIES

12.7.1 Overview

12.7.2 Types Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Febrile Seizure industry

Chapter 13 Appendix

LIST OF TABLES


Table 1 Febrile Seizure Industry Synopsis, 2020-2027

Table 2 Febrile Seizure Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Febrile Seizure Market by Region, 2020-2027, (USD Million)

Table 4 Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 5 Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)

Table 6 Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 7 Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)

Table 8 North America Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 9 North America Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)

Table 10 North America Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 11 North America Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)

Table 12 US Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 13 US Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)

Table 14 US Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 15 US Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)

Table 16 Canada Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 17 Canada Febrile Seizure market by Diagnosis, 2020-2027, (USD Million)

Table 18 Canada Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 19 Canada Febrile Seizure market by Distribution Channels, 2020-2027, (USD Million)

Table 20 South America Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 21 South America Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)

Table 22 South America Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 23 South America Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)

Table 24 Europe Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 25 Europe Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)

Table 26 Europe Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 27 Europe Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)

Table 28 Western Europe Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 29 Western Europe Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)

Table 30 Western Europe Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 31 Western Europe Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)

Table 32 Eastern Europe Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 33 Eastern Europe Febrile Seizure market by Diagnosis, 2020-2027, (USD Million)

Table 34 Eastern Europe Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 35 Eastern Europe Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)

Table 36 Asia Pacific Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 37 Asia Pacific Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)

Table 38 Asia Pacific Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 39 Asia Pacific Febrile Seizure market by Distribution Channels, 2020-2027, (USD Million)

Table 40 Middle East & Africa Febrile Seizure Market by Type, 2020-2027, (USD Million)

Table 41 Middle East & Africa Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)

Table 42 Middle East & Africa Febrile Seizure Market by Treatment, 2020-2027, (USD Million)

Table 43 Middle East & Africa Febrile Seizure market by Distribution Channels, 2020-2027, (USD Million)

LIST OF FIGURES


Figure 1 Research Process

Figure 2 Segmentation for Febrile Seizure Market

Figure 3 Segmentation Market Dynamics for Febrile Seizure Market

Figure 4 Global Febrile Seizure market Share, by Type 2020

Figure 5 Global Febrile Seizure market Share, by Diagnosis 2020

Figure 6 Global Febrile Seizure market Share, by Treatment 2020

Figure 7 Global Febrile Seizure market Share, by Distribution Channels, 2020

Figure 8 Global Febrile Seizure market Share, by Region, 2020

Figure 9 North America Febrile Seizure market Share, by Country, 2020

Figure 10 Europe Febrile Seizure market Share, by Country, 2020

Figure 11 Asia Pacific Febrile Seizure market Share, by Country, 2020

Figure 12 Middle East & Africa Febrile Seizure market Share, by Country, 2020

Figure 13 Global Febrile Seizure market: Company Share Analysis, 2020 (%)

Figure 14 Sanofi: Key Financials

Figure 15 Sanofi Segmental Revenue

Figure 16 Sanofi: Geographical Revenue

Figure 17 Cardinal Health: Key Financials

Figure 18 Cardinal Health: Segmental Revenue

Figure 19 Cardinal Health: Geographical Revenue

Figure 20 Merck: Key Financials

Figure 21 Merck: Segmental Revenue

Figure 22 Merck: Geographical Revenue

Figure 23 Pfizer: Key Financials

Figure 24 Pfizer: Segmental Revenue

Figure 25 Pfizer: Geographical Revenue

Figure 26 Johnson & Johnson: Key Financials

Figure 27 Johnson & Johnson: Segmental Revenue

Figure 28 Johnson & Johnson Geographical Revenue

Figure 29 Johnson & Johnson Private Limited: Key Financials

Figure 30 Johnson & Johnson Private Limited: Segmental Revenue

Figure 31 Johnson & Johnson Private Limited: Geographical Revenue

Figure 32 ABBOTT LABORATORIES: Key Financials

Figure 33 ABBOTT LABORATORIES: Segmental Revenue

Figure 34 ABBOTT LABORATORIES: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.